ClinicalTrials.Veeva

Menu

Short Post-surgical Antibiotic Therapy in Spine Infections - a Prospective, Randomized, Unblinded, Non-inferiority Trial

B

Balgrist University Hospital

Status

Enrolling

Conditions

Infection

Treatments

Drug: duration of standard antibiotic therapy

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

We implement a prospective, randomized, unblinded, non-inferiority trial regarding the duration of systemic, targeted antibiotic therapy after the first surgical debridement for spine infection; randomizing 1:1 between

  1. Six and twelve weeks of antibiotic therapy if there is an implant left in place
  2. Three and six weeks of antibiotic therapy if there is no implant left

Enrollment

236 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Spine surgery and intraoperative debridement with any technique
  • At least 12 months of scheduled follow-up from hospitalization
  • Bacterial spine infection of any nature, independently of implants or co-morbidities

Exclusion criteria

  • Mycobacterial, fungal, nocardial, and Actinomyces infections in the spine
  • Non-resected cancer in the infection site
  • Bone marrow or recent solid organ transplant patient (Recent: <5 years)
  • Any other infection in the patient requiring more than 6 weeks of antibiotic therapy
  • More than three intraoperative debridements performed for spine infection
  • Absence of at least one surgical intraoperative debridement of infection

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

236 participants in 2 patient groups

short antibiotic therapy
Experimental group
Description:
3 weeks of antibiotic therapy with no implant left in place 6 weeks of antibiotic therapy with implant left in place
Treatment:
Drug: duration of standard antibiotic therapy
long antibiotic therapy
Active Comparator group
Description:
6 weeks of antibiotic therapy with no implant in place 12 weeks of antibiotic therapy with implant left in place
Treatment:
Drug: duration of standard antibiotic therapy

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Michael Betz, PD Dr med; Ilker Uckay, PD Dr med

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems